High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis



: Wurtz P, Raiko JR, Magnussen CG, Soininen P, Kangas AJ, Tynkkynen T, Thomson R, Laatikainen R, Savolainen MJ, Laurikka J, Kuukasjarvi P, Tarkka M, Karhunen PJ, Jula A, Viikari JS, Kahonen M, Lehtimaki T, Juonala M, Ala-Korpela M, Raitakari OT

Publisher: OXFORD UNIV PRESS

: 2012

: European Heart Journal

: EUROPEAN HEART JOURNAL

: EUR HEART J

: 18

: 33

: 18

: 2307

: 2316

: 10

: 0195-668X

DOI: https://doi.org/10.1093/eurheartj/ehs020(external)


High-throughput metabolite quantification, with new systemic biomarkers, improved risk stratification for subclinical atherosclerosis in comparison to conventional lipids and could potentially be useful for early cardiovascular risk assessment.



Last updated on 2024-26-11 at 22:22